The reorganization and integration of pharmaceutical circulation industry will increase or change dramatically

[expert opinion of chinapharma.com] in recent years, low-cost drugs are frequently out of stock, and even lead to phenomena such as black market price, overseas purchasing on behalf of others and manufacturing and selling fake drugs According to the opinions, the system of information collection, submission, analysis and consultation of drugs in short supply shall be established and improved, and measures such as fixed-point production, drug storage, emergency production and coordination shall be taken to ensure the supply of drugs in the market (picture source: Baidu picture) compared with the previous reform plan of "one party only" in the field of drugs, this reform "Trinity" has effectively formed multi linkage " Fu Hongpeng, a researcher at the Research Center for health development of the national health and Family Planning Commission, believes that this is a major reform in the field of medicine in China, which will have far-reaching significance in further eliminating the burden of medicine to supplement medicine and reducing the cost of medicine in the whole society One end of drug circulation is connected with production supply and the other end is connected with terminal demand Fu Hongpeng said that in view of some chaos in the field of drug circulation, the opinions put forward new measures from seven aspects of drug circulation reform In the later stage, a number of supporting documents will be issued The reorganization and integration of the pharmaceutical circulation industry will be increased, and some may even have subversive changes "Two vote system", rational drug use and cooperation, some drugs with high prices and unreasonable growth of medical costs, has long been criticized by the grassroots masses In the opinion, it is clear that the "two ticket system" for drug purchase and sale will be promoted nationwide by 2018; the policy of classified drug purchase and sale will be implemented to reduce the false high price of drugs; the management of drug purchase and sale contracts will be strengthened, and corresponding penalties will be borne in case of violation of the contract; prominent problems in the field of drug circulation will be rectified, illegal enterprises, medical institutions and relevant responsible personnel will be severely punished according to law, and recorded as drugs Product purchasing and bad credit records of enterprise units and individuals "To solve the problem of inflated drug prices through the reform of the circulation field is only one of the means, and the real purpose is to control the cost." According to Ding Jinxi, a professor at China Pharmaceutical University, the opinion clearly further breaks the mechanism of supplementing medical treatment with drugs, cancels drug markup, adjusts the price of medical services, implements the responsibility of government investment, and speeds up the establishment of a new mechanism of compensation for public hospitals In order to seek the fundamental solution, the opinion also emphasizes "rational use of drugs" It is clear that public hospitals should fully equip and give priority to the use of essential drugs, implement the prescription review system, and give full play to the role of pharmacists in promoting rational use of drugs In recent years, low-cost drugs are frequently out of stock, and even lead to the phenomenon of black market price, overseas purchasing and fake drugs According to the opinions, the system of information collection, submission, analysis and consultation of drugs in short supply shall be established and improved, and measures such as fixed-point production, drug storage, emergency production and coordination shall be taken to ensure the supply of drugs in the market Wu Zhen, deputy director of the State Food and drug administration, said that the State Food and Drug Administration had accelerated the review of drugs in short supply By the end of 2016, the State Food and Drug Administration had released 12 batches of 155 priority review directories for registration applications, including 15 children's drugs As a special commodity, promoting the quality and efficacy consistency evaluation of generic drugs is directly related to people's health and life safety The opinions are clear and the review and approval of drug listing are strict We will optimize the review and approval procedures, speed up the review and approval of new drugs and drugs in short supply that are urgently needed in clinical practice, and speed up the evaluation of the consistency of the quality and efficacy of generic drugs on the market To evaluate the consistency of the generic drugs that have been approved for marketing is "a lesson to supplement history" Niu Zhengqian, vice president of China Pharmaceutical Enterprises Association, said that in the past, the drugs we approved for marketing did not meet the mandatory requirements of consistency evaluation with the original research drugs, and there were some gaps between some drugs and the original research drugs in terms of efficacy.